Serpex
6 online
Domain profile · Jun–Aug 2026Status · Live
newenglandsurro.com logo

newenglandsurro.com↗

Gestational Surrogacy Agency | Bright Futures Families

#6,934,460Link-graph rank
Top 5.8%of 119.7M domains
PageRank #9,889,558By links pointing at it
1 hostSubdomains in the link graph
About

Bright Futures Families is a national agency connecting intended parents with gestational surrogates nationwide. Start your journey today.

Technologies
Frontend · 2
Adobe FontsTypekit
Site details
Websitebrightfuturesfamilies.com ↗
Site languageAmerican English
Last read22 Sep 2026
RedirectRedirects to brightfuturesfamilies.com
Similar sites

Sites ranked next to it

RankSiteDescriptionTechnologies
6934455alvarius.com logoalvarius.comalvarius.com

Healing through psychedelic therapies Alvarius is an Irish bio-pharmaceutical company researching and developing unique therapies to target addiction through the pioneering use of 5-MeO-DMT medicines. About Us Alvarius is an Irish bio-pharmaceutical company researching and developing unique therapies to target addiction through the pioneering use of 5-MeO-DMT medicines. Alvarius aims to help patients overcome addictive […]

Yoast SEO+3
6934457delta-hospital.com logodelta-hospital.comdelta-hospital.com

Delta-Hospital

Facebook Pixel
6934459medisafecanada.com logomedisafecanada.commedisafecanada.com

copper IUDs, Dilapan-S, FemmyCycle, FemCap, V-Fresh Plus, medical supplies, women’s health, diagnostics. Liberté IUD DUI - UT380, TT380 intrauterine devices

Yoast SEO+7
AdSerpex Search APIserpex.dev

The fast, affordable search API for AI & data projects.

Google Analytics
6934461opmarketing.com logoopmarketing.comopmarketing.com→ opsolutions.us

O&P software built for orthotics and prosthetics clinics. Compass combines EHR, practice management, clearinghouse and RCM to help prevent denials and get claims paid.

WordPress+4
6934462signettx.com logosignettx.comsignettx.com

希格生科是全球“类器官+AI”赋能创新靶向药研发模式的先行者、国家高新技术企业及专精特新企业。公司最初诞生于哈佛大学校园,于2020年底正式落地深圳,至今已完成近3亿元的融资及项目资助。公司目前布局多条First-in-class药物管线和一个类器官服务平台,其中核心管线SIGX1094作为全球首款弥漫性胃癌靶向药,先后获得了美国FDA和中国NMPA的IND,并获得美国FDA孤儿药资格认定(ODD)及快速通道认定(FTD)。该药物于2025年8月赢得“医药界诺贝尔奖”之称的盖伦奖提名,目前正在北京大学肿瘤医院进行Ⅰ期临床试验,并即将开展Ⅱ期临床试验。该管线也是全球首个经

Not checked yet

Is this your site? Request removal of the newenglandsurro.com page.